BioLight Life Sciences Ltd (BOLT)

Currency in ILS
371.4
-1.5(-0.40%)
Closed·
BOLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
358.0380.4
52 wk Range
314.1702.0
Key Statistics
Bid/Ask
371.40 / 400.00
Prev. Close
372.9
Open
372.9
Day's Range
358-380.4
52 wk Range
314.1-702
Volume
12.01K
Average Volume (3m)
17.5K
1-Year Change
-40.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

BioLight Life Sciences Ltd Company Profile

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company’s ophthalmic product offering and pipeline of product candidates include DiagnosTear’s TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival implant; OphRx that develops drugs for treating eye diseases; and Peripherex, which develops solutions for at-home and in-office diagnosis and monitoring of peripheral vision impairment used by eye care and other providers to diagnose and monitor glaucoma and other diseases. Its pipeline also include AEYE that develops artificial intelligence solutions for a variety of retinal diseases; Tarsier, which develops TRS 01 based on its technological platform for the treatment of Uveitis in patients suffering from high IPO; Belkin Vision that develops clinic fast and automatic laser device to enable glaucoma patients to receive short & effective treatments as treatment to lower IOP; and Sanoculis, which develops an innovative surgical procedure for the treatment of the Glaucoma. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Tel Aviv, Israel.

Compare BOLT to Peers and Sector

Metrics to compare
BOLT
Peers
Sector
Relationship
P/E Ratio
−2.4x−2.2x−0.6x
PEG Ratio
0.010.030.00
Price/Book
0.9x1.0x2.6x
Price / LTM Sales
1,600.1x0.8x3.3x
Upside (Analyst Target)
-114.5%40.0%
Fair Value Upside
Unlock22.5%3.2%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 23, 2025
EPS / Forecast
-0.45 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BOLT Income Statement

FAQ

What Is the Bio Light (BOLT) Stock Price Today?

The Bio Light stock price today is 371.4

What Stock Exchange Does Bio Light Trade On?

Bio Light is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Bio Light?

The stock symbol for Bio Light is "BOLT."

What Is the Bio Light Market Cap?

As of today, Bio Light market cap is 33.60M.

What Is Bio Light's Earnings Per Share (TTM)?

The Bio Light EPS (TTM) is -2.92.

From a Technical Analysis Perspective, Is BOLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Bio Light Stock Split?

Bio Light has split 4 times.

How Many Employees Does Bio Light Have?

Bio Light has 4 employees.

What is the current trading status of Bio Light (BOLT)?

As of Jan 10, 2026, Bio Light (BOLT) is trading at a price of 371.4, with a previous close of 372.9. The stock has fluctuated within a day range of 358.0 to 380.4, while its 52-week range spans from 314.1 to 702.0.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.